A study led by Clínic Barcelona Comprehensive Cancer Centre (4CB)- – driven by Clínic Barcelona, IDIBAPS and UB-, and sponsored by SOLTI, shows that1
MiWEndo Solutions and Reveal Genomics, spin-offs created by Clínic-IDIBAPS, have been selected among the ten innovative initiatives that will receive1
Hospital Clínic Barcelona and the FERO Foundation have signed an agreement whereby the foundation joins the Clínic Barcelona Comprehensive Cancer Cen1
The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastu1
Hospitals that are part of the C17 alliance have launched the C17 Integrated Cancer Network (XIC-C17), an initiative aimed at strengthening coordinat1
The Clínic Barcelona Comprehensive Cancer Center (4CB), a center promoted by Clínic, IDIBAPS and the University of Barcelona, has presented a total o1
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—toget1
The Scientific Foundation of the Spanish Association Against Cancer has created its own research centre accreditation system to ‘promote excellence i1
On March 25, the IDIBAPS facilities hosted the Kick-off meeting of the European project "Evaluation and optimization of proton arc therapy" known by1
On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Cance1
